ZIM Laboratories Limited (NSE:ZIMLAB)
68.10
+0.63 (0.93%)
Apr 6, 2026, 3:29 PM IST
ZIM Laboratories Market Cap
ZIM Laboratories has a market cap or net worth of 3.6 billion as of April 6, 2026. Its market cap has decreased by -10.42% in one year.
Market Cap
3.60B
Enterprise Value
4.78B
Revenue
3.78B
Ranking
n/a
PE Ratio
51.57
Stock Price
68.10
Market Cap Chart
Since June 11, 2018, ZIM Laboratories's market cap has increased from 1.68B to 3.60B, an increase of 114.13%. That is a compound annual growth rate of 10.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 3.60B | 2.78% |
| Dec 31, 2025 | 3.50B | -33.11% |
| Dec 31, 2024 | 5.24B | -6.72% |
| Dec 29, 2023 | 5.62B | 18.57% |
| Dec 30, 2022 | 4.74B | 146.60% |
| Dec 31, 2021 | 1.92B | 31.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beta Drugs | 14.00B |
| Jagsonpal Pharmaceuticals | 12.47B |
| Ind-Swift Laboratories | 12.04B |
| Sakar Healthcare | 11.47B |
| Sigachi Industries | 7.39B |
| Valiant Laboratories | 3.11B |
| Bafna Pharmaceuticals | 2.63B |
| Nectar Lifesciences | 1.95B |